VITL, a Nashville-based healthtech company focused on infrastructure for cash-pay healthcare, announced it has raised $7.5 million in a Series A funding round led by SignalFire. The company plans to use the capital to expand its pharmacy network, accelerate product development, and grow its team as it targets inefficiencies in a rapidly growing segment of the healthcare market.
The company is building what it describes as an operating system for cash-pay healthcare, aiming to replace fragmented and manual workflows that clinics currently rely on. Unlike traditional healthcare systems designed around insurance-based care, VITL focuses on preventative and cash-pay models such as med spas, hormone clinics, concierge medicine, and direct primary care.
VITL addresses a major operational gap where clinics must manually coordinate pharmacy processes, including credentialing with multiple pharmacies, tracking prescriptions, managing inventory shortages, and handling fulfillment logistics. These inefficiencies can cost clinics over $100,000 annually and consume up to two full workdays per month for physicians.
The platform consolidates these workflows into a single interface, allowing providers to access multiple pharmacies with a single login, compare real-time pricing across verified compounding pharmacies, place multi-pharmacy orders in a single transaction, and track prescriptions from order to delivery. The goal is to reduce administrative burden while improving transparency and patient experience.
Since launching in late 2024, VITL has scaled بسرعة, reporting more than 630 clinics on its platform and over 1,000 active prescribers. The company has achieved eight-figure annual recurring revenue within two years and reports more than 90% quarter-over-quarter order growth. Clinics using the platform report significant efficiency gains, including saving two full workdays per month on prescription management and reducing costs by approximately $100,000 annually.
The company attributes its growth to structural shifts in healthcare, including rising consumer demand for transparency and access, regulatory changes affecting compounding pharmacies, and the limitations of legacy e-prescribing systems designed for insurance-driven care.
VITL plans to use the new funding to expand its network of verified pharmacy partners, build additional clinical program management and subscription tools, enhance interoperability with the broader healthcare ecosystem, and scale operations from its Nashville headquarters.
The company serves a range of cash-pay medical practices, including med spas, peptide clinics, anti-aging centers, weight loss clinics, and functional medicine providers, connecting them with compliant 503A and 503B compounding pharmacies nationwide.
SignalFire, which led the round, identified VITL through its data-driven sourcing platform and initiated the investment without a traditional fundraising process.
KEY QUOTES:
“We’re not building another healthcare tool. We’re building infrastructure that eliminates the need for most of them. E-prescribing was the first and most obvious source of drag we eliminated. But it’s not the last. We’re not building another healthcare tool. We’re building infrastructure that eliminates the need for most of them. Every workflow, every manual step, every phone call, every redundant credential, if it creates drag for a cash-pay clinic and it isn’t treating a patient, we want to remove it.”
Charlie Jordan, Founder and CEO, VITL
“Cash-pay healthcare represents one of the fastest-growing segments of the U.S. healthcare market, yet it’s running on infrastructure designed decades ago. VITL is bringing modern marketplace dynamics and consumer-grade user experience to an industry desperately in need of innovation. Charlie and his team have built exactly what physicians have been asking for.”
Chris Scoggins, General Partner, SignalFire
